Back to FAYEZ SAROFIM & CO FAYEZ SAROFIM & CO

NVONVO
31 quarters

Position history for FAYEZ SAROFIM & COFAYEZ SAROFIM & CO's holdings in Novo Nordisk A/S

Yes. Fayez Sarofim holds 2,924,500 shares of NVO (Novo Nordisk), worth $140.2M, as of its Q2 2026 13F filing. It reduced the position by 470,979 shares (-13.9%) from Q1 2026. Fayez Sarofim has held NVO in every 13F on record since Q4 2018, 31 quarterly filings. NVO is 0.3% of Fayez Sarofim's reported 13F portfolio.

Current Value

$140.2M

Current Shares

2.9M

Total Value Change

-$65.3M

Total Shares Change

-1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.9M
-13.9%
$140.2M0.3%$47.34
0
2026-Q1
Decreased
3.4M
-19.8%
$124.8M0.3%$36.29
0
2025-Q4
Decreased
4.2M
-42.4%
$215.5M0.5%$48.46
0
2025-Q3
Decreased
7.4M
-30.0%
$408.1M0.9%$52.85
0
2025-Q2
Decreased
10.5M
-6.3%
$725M1.7%$65.01
0
2025-Q1
Decreased
11.2M
-1.5%
$778.6M1.9%$65.40
0
2024-Q4
Decreased
11.4M
-6.8%
$979.3M2.4%$79.73
0
2024-Q3
Decreased
12.2M
-2.7%
$1.5B3.7%$110.37
0
2024-Q2
Increased
12.6M
+6.2%
$1.8B4.8%$131.81
62
2024-Q1
Increased
11.8M
+0.0%
$1.5B4.5%$118.57
58
2023-Q4
Increased
11.8M
+1.8%
$1.4B4.4%$94.85
60
2023-Q3
Increased
11.6M
+126.7%
$1.1B3.6%$83.38
94
2023-Q2
Decreased
5.1M
-3.0%
$828.5M2.9%$73.83
0
2023-Q1
Increased
5.3M
+3.2%
$840.3M2.9%$72.60
56
2022-Q4
Decreased
5.1M
-1.9%
$692.4M2.6%$61.25
0
2022-Q3
Increased
5.2M
+9.4%
$519.9M2.1%$45.09
59
2022-Q2
Increased
4.8M
+0.0%
$531.3M1.9%$50.16
49
2022-Q1
Decreased
4.8M
-1.4%
$529.4M1.7%$49.99
0
2021-Q4
Decreased
4.8M
-1.8%
$541.2M1.6%$49.94
0
2021-Q3
Decreased
4.9M
-0.2%
$472.6M1.6%$42.81
0
2021-Q2
Decreased
4.9M
-0.7%
$413.1M1.4%$37.15
0
2021-Q1
Decreased
5M
-0.4%
$334.8M1.2%$29.90
0
2020-Q4
Decreased
5M
-0.3%
$348.1M1.3%$30.54
0
2020-Q3
Decreased
5M
-1.2%
$347.2M1.5%$30.36
0
2020-Q2
Increased
5.1M
+19.8%
$331.5M1.5%$28.41
58
2020-Q1
Decreased
4.2M
-4.1%
$254.3M1.6%$26.12
0
2019-Q4
Decreased
4.4M
-2.5%
$254.9M1.2%$24.76
0
2019-Q3
Increased
4.5M
+0.8%
$233.7M1.2%$22.12
49
2019-Q2
Increased
4.5M
+0.3%
$228.9M1.2%$21.64
48
2019-Q1
Increased
4.5M
+0.3%
$233.9M1.2%$22.18
48
2018-Q4
First report
4.5M
-
$205.5M1.2%$19.24
0

Other major holders of NVO: JENNISON ASSOCIATES LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used